232 related articles for article (PubMed ID: 32596207)
1. Strategies to Investigate Ubiquitination in Huntington's Disease.
Sap KA; Reits EA
Front Chem; 2020; 8():485. PubMed ID: 32596207
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-modifying enzymes in Huntington's disease.
Sap KA; Geijtenbeek KW; Schipper-Krom S; Guler AT; Reits EA
Front Mol Biosci; 2023; 10():1107323. PubMed ID: 36926679
[TBL] [Abstract][Full Text] [Related]
3. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.
Lin L; Jin Z; Tan H; Xu Q; Peng T; Li H
Brain Res; 2016 Jul; 1643():103-12. PubMed ID: 27107943
[TBL] [Abstract][Full Text] [Related]
4. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.
Luo H; Cao L; Liang X; Du A; Peng T; Li H
Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620
[TBL] [Abstract][Full Text] [Related]
5. Degradation of mutant huntingtin via the ubiquitin/proteasome system is modulated by FE65.
Chow WN; Luk HW; Chan HY; Lau KF
Biochem J; 2012 May; 443(3):681-9. PubMed ID: 22352297
[TBL] [Abstract][Full Text] [Related]
6. MnFe
Zhang L; Wei PF; Song YH; Dong L; Wu YD; Hao ZY; Fan S; Tai S; Meng JL; Lu Y; Xue J; Liang CZ; Wen LP
Biomaterials; 2019 Sep; 216():119248. PubMed ID: 31226569
[TBL] [Abstract][Full Text] [Related]
7. Detection of ubiquitinated huntingtin species in intracellular aggregates.
Juenemann K; Wiemhoefer A; Reits EA
Front Mol Neurosci; 2015; 8():1. PubMed ID: 25674046
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-specific protease-14 reduces cellular aggregates and protects against mutant huntingtin-induced cell degeneration: involvement of the proteasome and ER stress-activated kinase IRE1α.
Hyrskyluoto A; Bruelle C; Lundh SH; Do HT; Kivinen J; Rappou E; Reijonen S; Waltimo T; Petersén Å; Lindholm D; Korhonen L
Hum Mol Genet; 2014 Nov; 23(22):5928-39. PubMed ID: 24951540
[TBL] [Abstract][Full Text] [Related]
9. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
[TBL] [Abstract][Full Text] [Related]
10. The Ubiquitin-Proteasome System in Huntington's Disease: Are Proteasomes Impaired, Initiators of Disease, or Coming to the Rescue?
Schipper-Krom S; Juenemann K; Reits EA
Biochem Res Int; 2012; 2012():837015. PubMed ID: 23050151
[TBL] [Abstract][Full Text] [Related]
11.
Kohli H; Kumar P; Ambasta RK
Heliyon; 2021 Feb; 7(2):e06088. PubMed ID: 33659724
[TBL] [Abstract][Full Text] [Related]
12. The Ubiquitin Receptor ADRM1 Modulates HAP40-Induced Proteasome Activity.
Huang ZN; Her LS
Mol Neurobiol; 2017 Nov; 54(9):7382-7400. PubMed ID: 27815841
[TBL] [Abstract][Full Text] [Related]
13. The P42 peptide and Peptide-based therapies for Huntington's disease.
Marelli C; Maschat F
Orphanet J Rare Dis; 2016 Mar; 11():24. PubMed ID: 26984770
[TBL] [Abstract][Full Text] [Related]
14. Molecular Strategies to Target Protein Aggregation in Huntington's Disease.
Jarosińska OD; Rüdiger SGD
Front Mol Biosci; 2021; 8():769184. PubMed ID: 34869596
[TBL] [Abstract][Full Text] [Related]
15. Siah-1-interacting protein regulates mutated huntingtin protein aggregation in Huntington's disease models.
Latoszek E; Wiweger M; Ludwiczak J; Dunin-Horkawicz S; Kuznicki J; Czeredys M
Cell Biosci; 2022 Mar; 12(1):34. PubMed ID: 35305696
[TBL] [Abstract][Full Text] [Related]
16. Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A.
Bhat KP; Yan S; Wang CE; Li S; Li XJ
Proc Natl Acad Sci U S A; 2014 Apr; 111(15):5706-11. PubMed ID: 24706802
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-proteasome system involvement in Huntington's disease.
Ortega Z; Lucas JJ
Front Mol Neurosci; 2014; 7():77. PubMed ID: 25324717
[TBL] [Abstract][Full Text] [Related]
18. Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease.
Miki Y; Tanji K; Mori F; Wakabayashi K
Neurobiol Dis; 2015 Feb; 74():25-31. PubMed ID: 25449906
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
Lee WC; Yoshihara M; Littleton JT
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
[TBL] [Abstract][Full Text] [Related]
20. The flavonoid luteolin reduces mutant huntingtin aggregation and cytotoxicity in huntingtin-mutated neuroblastoma cells.
Ramadan A; Mohammed A; Elnour AA; Sadeq A; Al Mazrouei N; Alkaabi M; Al-Kubaisi KA; Beshir SA; Menon V; AlAmoodi A; Sam KG; Saeed AAAM; Abdalla SF; Hussein SM
Saudi Pharm J; 2023 Dec; 31(12):101871. PubMed ID: 38125952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
